Drugs / BAY1006578
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01153607 | Jun 2010 → Oct 2011 | — | Lantheus Biosciences Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1006578 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01153607 ↗ |
| Route | Intravenous | “Single intravenous bolus injection of 250 MBq BAY1006578” NCT01153607 ↗ |